| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061581 Nuclelotide sequences coding immunoglobulin segment; for use in diagnosis and prevention of viral infection and disease |
| 05/23/2002 | US20020061571 Novel isoform of myotonic dystrophy associated protein kinase and uses thereof |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 05/23/2002 | US20020061557 Composition for use in the diagnosis and treatment of fertility defects, mammary gland and prostate cancers, osteoporosis, urogenital disorders and grave's disease |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061551 Nucleotide sequences coding a regulatory protein for use in the treatment of tumors, arteriosclerosis, autoimmune and diseases, blood disorders, asthma, arthritis and leukemia |
| 05/23/2002 | US20020061549 Balancing physical properties of a polypeptide; obtain sample, crosslink tyrosine residues, monitor physical properties of polypeptide |
| 05/23/2002 | US20020061545 Streptococcus pneumoniae antigens and vaccines |
| 05/23/2002 | US20020061543 Diagnosing cancer in humans; obtain tissue, monitor transcription factor expression, compare to control, amplified expression indicates cancer |
| 05/23/2002 | US20020061542 Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood |
| 05/23/2002 | US20020061541 Diagnosis of endometrial precancers |
| 05/23/2002 | US20020061524 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology |
| 05/23/2002 | US20020061305 Anti-CCR1 antibodies and methods of use therefor |
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | US20020061296 Nond-denatured apoptin (with fusion protein or tag) as anticancer, anti-autoimmune disease therapeutic proteins (HIV TAT proteins) |
| 05/23/2002 | DE10126367A1 Pharmaceutical composition comprises Borrelia antigens and encoding nucleic acid, useful for diagnosis, treatment and prevention of Lyme borreliosis |
| 05/23/2002 | DE10057443A1 Use of specific antibodies, or individual chains, for treating tumors and vascular occlusions, by inhibition of the gpIIb/IIIa receptor |
| 05/23/2002 | CA2856033A1 Use of a monoclonal antibody specific for a leukocyte to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
| 05/23/2002 | CA2467781A1 Use of a monoclonal antibody specific for a red blood cell to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429140A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2002 | CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427010A1 Transporters and ion channels |
| 05/22/2002 | EP1207395A1 Method for measuring kinase activity of cyclin/cdk complex |
| 05/22/2002 | EP1207203A2 DNA sequence and papillomavirus vaccine |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207168A1 Polypeptides and nucleic acids encoding the same |
| 05/22/2002 | EP1206702A1 Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody |
| 05/22/2002 | EP1206701A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 05/22/2002 | EP1206576A1 Novel kinases and uses thereof |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206555A1 F v? antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206550A1 Proteins derived from white spot syndrome virus and uses thereof |
| 05/22/2002 | EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206544A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206535A1 Tumor-associated antigen (r11) |
| 05/22/2002 | EP1206530A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206494A1 Computational design methods for making molecular mimetics |
| 05/22/2002 | EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206479A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206274A2 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/22/2002 | EP1206234A2 Methods and compositions for modulating cell proliferation and cell death |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP0720623B1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | CN1350585A i(Neisseria meningitidis) polypeptide BASBO52 |
| 05/22/2002 | CN1350580A Method of cel cultivation |
| 05/22/2002 | CN1350549A Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392024 Nucleotide sequences coding freeze resistant polypeptide; for use in food processing and organ transplants |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
| 05/21/2002 | US6391857 Methods and compositions for endothelial binding |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391847 Modulating transcription |
| 05/21/2002 | US6391657 Removal of viruses from protein solutions by ultrafiltration |
| 05/21/2002 | US6391655 Oxidized styrenic polymers for DNA binding |
| 05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
| 05/21/2002 | US6391635 Monoclonal human natural antibodies |
| 05/21/2002 | US6391634 Monoclonal antibodies and their production and use |
| 05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
| 05/21/2002 | US6391587 Nucleotide sequences for use in the prevention of microorganismal infections |
| 05/21/2002 | US6391584 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 05/21/2002 | US6391581 DNA encoding interleukin-4 receptors |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 05/21/2002 | US6391567 Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| 05/21/2002 | US6391566 Drug screening of ligands which interact with receptor of defined amino acid sequence incubating by incubating ligand with recombinant cell or membrane which expresses receptor |
| 05/21/2002 | US6391563 Method for the determination of antigens with the aid of three or more monoclonal antibodies |
| 05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
| 05/21/2002 | US6391315 Composition comprising mixed antigens derived from both cell surface extracts and cultured broth, treated by chromatography to obtain effective fraction free of endotoxin and whole cells |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391302 Method for treating cancers which present antigen FB5 with humanized antibodies |
| 05/21/2002 | US6391301 Agent for identifying and treating metastasizing tumors |
| 05/21/2002 | US6391299 Anti-factor IX/IXa antibodies |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/21/2002 | US6391280 J chain polypeptide targeting molecule linked to an imaging agent |